Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 1c, Revenues Beat

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.87, $0.01 better than the analyst estimate of $1.86. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.

"We delivered another solid quarter, driven by overall strong performance in the Asia Pacific and Europe, Middle East and Africa regions," said Bryan Hanson, President and CEO of Zimmer Biomet. "Our accomplishments this quarter affirm our confidence in the progress we are making to turn around the business. Recently launched products and platform technologies will enable our sales force to leverage our complete ecosystem of differentiated solutions and return to offense in the second half of the year."

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance
• Oil-Dri raises dividend for 23rd consecutive year, authorizes buybacks